Global Search | Novartis

Hide Filters

Sort by

Relevance

Newest first

Oldest first

Showing 24 results

Media Release / Aug 28, 2024
Novartis twice-yearly* Leqvio® demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in patients at low or moderate ASCVD risk
Phase III V-MONO study met its primary endpoints, demonstrating superiority of Leqvio (inclisiran) monotherapy vs both placebo and ezetimibe in LDL-C reduction1 Results add to growing body of…
Media Release / Sep 11, 2024
Media Release
Featured News / Apr 23, 2024
Novartis Financial Results – Q1 2024
Novartis announced the company’s financial results for the first quarter of 2024.
Story / Dec 08, 2023
Shoulder to shoulder
Patient Perspectives
People with breast cancer need better medicines that help reduce the risk and anxiety of it returning.